RYAM CEO to Present at Gabelli Specialty Chemicals Symposium
Event summary
- RYAM CEO Scott Sutton to present at Gabelli Funds’ 17th Annual Specialty Chemicals Symposium on March 19, 2026.
- Event includes one-on-one investor meetings in New York City.
- RYAM generated $1.5 billion in revenue in 2025.
- Company operates manufacturing facilities in the U.S., Canada, and France.
The big picture
RYAM’s participation in the Gabelli Specialty Chemicals Symposium underscores the company’s focus on engaging with investors amid a dynamic specialty chemicals market. As a global leader in cellulose and derivatives, RYAM’s strategic positioning and operational scale will be key topics of discussion, particularly in the context of broader industry trends and competitive dynamics.
What we're watching
- Investor Sentiment
- How CEO Scott Sutton’s presentation will impact investor confidence in RYAM’s strategic direction.
- Market Positioning
- Whether RYAM can leverage the symposium to highlight its competitive advantages in the specialty chemicals sector.
- Operational Strategy
- The pace at which RYAM can translate its global manufacturing capabilities into sustained revenue growth.
Related topics